Hyun Kim, MD, was recently selected as an RTOG Foundation New Investigator Spotlight due to his various accomplishments and ongoing efforts in the oncology community. Dr. Kim is a physician treating patients with gastrointestinal (GI) malignancies as well as the Chief of GI Oncology Service and Chief of MR Clinical Services in the Department of Radiation Oncology at Washington University St. Louis. His focus is on nonoperative and adaptive radiation therapy to improve outcomes in GI cancers, especially rectal, pancreas, gastric, and liver tumors. Dr. Kim serves as the co-leader for both lower and upper GI focus groups at Siteman Cancer Center.
Additionally, he served as the principal investigator for multiple investigator-initiated trials, including trials evaluating short course radiation followed by multi-agent chemotherapy for nonoperative management of rectal adenocarcinoma (NORMAL-R), full-dose gemcitabine/abraxane with concurrent MR-guided radiotherapy (MRgRT) in locally advanced pancreas cancer, MR-guided adaptive radiation therapy in gastric adenocarcinoma, adaptive palliative radiation therapy without the traditionally requisite CT simulation scan and a clinical trial where we obtained first-in-world images with a novel ring-gantry imaging system that has the image quality and potential for adaptive radiation therapy in CT-based radiation therapy units.